These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29226122)

  • 1. Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?
    Mortensen LA; Bistrup C; Thiesson HC
    Front Med (Lausanne); 2017; 4():210. PubMed ID: 29226122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial).
    Mortensen LA; Thiesson HC; Tougaard B; Egfjord M; Fischer ASL; Bistrup C
    BMC Nephrol; 2018 May; 19(1):105. PubMed ID: 29724188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.
    Bobadilla NA; Gamba G
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F2-9. PubMed ID: 17429034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach.
    Pallet N; Legendre C
    Pharmacogenomics; 2010 Oct; 11(10):1491-501. PubMed ID: 21047207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
    Sun QL; Li M; Rui HL; Chen YP
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel action of aldosterone in CsA nephrotoxicity].
    Pérez-Rojas JM; Bobadilla NA
    Rev Invest Clin; 2005; 57(2):147-55. PubMed ID: 16524053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin nephrotoxicity.
    Williams D; Haragsim L
    Adv Chronic Kidney Dis; 2006 Jan; 13(1):47-55. PubMed ID: 16412970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts.
    Liptak P; Ivanyi B
    Nat Clin Pract Nephrol; 2006 Jul; 2(7):398-404; quiz following 404. PubMed ID: 16932468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity.
    Chang HR; Lee MH; Wen MC; Lian JD
    Transplant Proc; 2004 Nov; 36(9):2668-70. PubMed ID: 15621119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of calcineurin inhibitors induced-nephrotoxicity].
    Kamar N; Rostaing L
    Nephrol Ther; 2008 Jun; 4 Suppl 1():S13-S17. PubMed ID: 18703392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
    Takeda Y; Yoneda T; Demura M; Usukura M; Mabuchi H
    Circulation; 2002 Feb; 105(6):677-9. PubMed ID: 11839620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinicopathological impact of calcineurin inhibitor cessation without specific cytoreductive induction in kidney transplantation.
    Tanabe T; Morita K; Fujita H; Hatanaka K; Ogawa Y; Hirose T; Sasaki H; Iwami D; Hotta K; Nonomura K
    Clin Transplant; 2013; 27 Suppl 26():9-13. PubMed ID: 24299230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice.
    Park HS; Kim EN; Kim MY; Lim JH; Kim HW; Park CW; Yang CW; Jin DC; Choi BS
    Transpl Immunol; 2016 Feb; 34():42-9. PubMed ID: 26603313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitor-induced renal allograft nephrotoxicity.
    Krejci K; Tichy T; Bachleda P; Zadrazil J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):297-306. PubMed ID: 21293540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.